107 related articles for article (PubMed ID: 10716091)
1. Bipolaris spicifera meningitis complicating a neurosurgerical procedure.
Latham RH
Scand J Infect Dis; 2000; 32(1):102-3. PubMed ID: 10716091
[TBL] [Abstract][Full Text] [Related]
2. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Bipolaris infection in a neutropenic patient with acute lymphoblastic leukemia.
Bilu D; Movahedi-Lankarani S; Kazin RA; Shields C; Moresi M
J Cutan Med Surg; 2004; 8(6):446-9. PubMed ID: 16189723
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Gómez-López A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
J Antimicrob Chemother; 2001 Dec; 48(6):919-21. PubMed ID: 11733480
[TBL] [Abstract][Full Text] [Related]
5. Unilateral renal phaeohyphomycosis due to Bipolaris spicifera in an immunocompetent child - rare case presentation and review of literature.
Kaur R; Bala K
Mycoses; 2015 Jul; 58(7):437-44. PubMed ID: 26058420
[TBL] [Abstract][Full Text] [Related]
6. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Johnson EM; Szekely A; Warnock DW
J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897
[TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
[TBL] [Abstract][Full Text] [Related]
9. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
González GM
Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of voriconazole against selected fungi.
McGinnis MR; Pasarell L; Sutton DA; Fothergill AW; Cooper CR; Rinaldi MG
Med Mycol; 1998 Aug; 36(4):239-42. PubMed ID: 9776841
[TBL] [Abstract][Full Text] [Related]
12. Scedosporium apiospermum keratitis treated with itraconazole.
Saracli MA; Erdem U; Gonlum A; Yildiran ST
Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Marco F; Pfaller MA; Messer SA; Jones RN
Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Morace G; Drago M; Scaltrito MM; Conti S; Fanti F; Polonelli L;
J Chemother; 2007 Oct; 19(5):508-13. PubMed ID: 18073149
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of amphotericin B and itraconazole against filamentous fungi: comparison of the Sensititre Yeast One and NCCLS M38--a reference methods.
Carrillo-Muñoz AJ; Quindós G; Del Valle O; Hernández-Molina JM; Santos P
J Chemother; 2004 Oct; 16(5):468-73. PubMed ID: 15565914
[TBL] [Abstract][Full Text] [Related]
16. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Silva V; Zepeda G; Alvareda D
Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
Silvanose CD; Bailey TA; Di Somma A
Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
Carrillo-Muñoz AJ; Ruesga M; Brio S; del Valle O; Rodriguez V; Santos P; Hernández-Molina JM; Cantón E; Pemán J; Guarro J; Quindós G
Chemotherapy; 2002 Dec; 48(5):224-31. PubMed ID: 12476038
[TBL] [Abstract][Full Text] [Related]
19. Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.
Lamoth F; Damonti L; Alexander BD
J Clin Microbiol; 2016 Jun; 54(6):1638-1640. PubMed ID: 27008871
[TBL] [Abstract][Full Text] [Related]
20. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]